Foot And Mouth Disease (FMD) Vaccines Market Size, Share, Growth, and Industry Analysis, By Type (Emergency Vaccines, Conventional Vaccines), By Application (Cattle, Pig, Sheep and Goat), and Regional Forecast to 2035.

FOOT AND MOUTH DISEASE (FMD) VACCINES MARKET OVERVIEW:

The global Foot And Mouth Disease (FMD) Vaccines Market size estimated at USD 1377.1 million in 2026 and is projected to reach USD 1813 million by 2035, growing at a CAGR of 9.6% from 2026 to 2035.

The Vaccines for FMD market is spurred by the need to check and inhibit the spread of the viral illness that infects livestock including cattle, sheep, pigs, and other animals. Market is expanding as there are more and more outbreaks, economic effect of the disease and need to protect food supply chain around the globe. FMD vaccines are most popular where the disease is most prevalent and these include parts of Asia, Africa and the Middle East. More attention is paid to creation of new more effective and long acting vaccines and state supported immunization campaigns. Stakeholders in the market are working on new and enhanced mechanisms in biotechnology, there have been strategic plans for efficient storage and distribution for vaccines, and penetration to new regions. Growths in average awareness of the farmer and steps in veterinary healthcare are also spurring on the market growth.

• • 

    Request a Free sample to learn more about this report.

KEY FINDINGS

• Market Size and Growth: The Foot And Mouth Disease (FMD) Vaccines Market Market size was USD 1146.42 Million in 2024, is projected to grow to USD 1192.55 Million by 2025 and exceed USD 1509.3 Million by 2033, with a CAGR of 9.6% from 2025–2033.

• Key Market Driver: Outbreaks remain alarmingly frequent—over 70 countries reported FMD cases in the last five years, making preventive vaccination a cornerstone of livestock health programs.

• Major Market Restraint: Cold chain dependence adds logistical headaches in rural zones—over 40% of vaccine spoilage in developing regions is due to poor storage infrastructure.

• Emerging Trends: Thermostable vaccines are gaining traction, reducing reliance on constant refrigeration; early trials show 6-month shelf life at ambient temperatures.

• Regional Leadership: Asia-Pacific dominates demand, with countries like India vaccinating over 100 million cattle annually under national eradication campaigns.

• Competitive Landscape: Roughly 15 major players dominate the market, with Merial, Indian Immunologicals Ltd, and Brilliant Bio Pharma Ltd leading in volume production.

• Market Segmentation: The bivalent vaccine segment is the most widely adopted, accounting for more than 45% of total doses due to its cross-serotype protection against SAT and O types.

• Recent Development: In 2024, Kenya rolled out a national FMD monitoring system that digitizes vaccine tracking and disease reporting across 47 counties—covering over 22 million livestock heads.

COVID-19 IMPACT

"Foot and Mouth Disease (FMD) Vaccines Industry Had a Negative Effect Due to supply chain disruption during COVID-19 Pandemic"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic negatively impacted the Foot And Mouth Disease (FMD) Vaccines Market share place by disrupting global delivery chains. The process of vaccination got affected mostly due to the Lockdowns, restrictions on the movement of people and goods, shutdowns of the manufacturing units. Some countries widely reported constraint in deliverables and other components required in the formulation of the vaccines adjuvants and preservatives for example. Transportation congestion and lack of human resource also compounded the problem by delaying the distribution of vaccines to the areas more hardest hit with FMD diseases. The COVID-19 burden to the health systems also pull focus and investment on livestock diseases causing delay in immunization campaign that increased FMD risks and losses among the livestocks.

LATEST TREND

"Rising Demand in Livestock Farming  to Drive Market Growth"

The high demand for livestock products in the global market is the major factor that has been observed to drive the Foot And Mouth Disease (FMD) Vaccines Market. With population growth as well as raising per capita incomes, particularly in the emerging economies the demand for meat, milk and other livestock products is on the rise. This has for instance called for disease control in the livestock and has promoted the use of FMD vaccines. For this reason, governments and organizations are placing more emphasis on prevention of FMD epidemics in order to protect food security and the agricultural sectors’ financial stability.

• • 

    Request a Free sample to learn more about this report.

FOOT AND MOUTH DISEASE (FMD) VACCINES MARKET SEGMENTATION

BY TYPE

Based on Type, the global market can be categorized into Emergency Vaccines, Conventional Vaccines

• Emergency Vaccines: The Emergency Vaccines of FMD are normally used in crisis since any form of FMD signifies a breakdown of normal control measures. These vaccines have a very important role in the prevention of disease especially in the case of areas in which FMD is not prevalent or how areas in which the livestock is highly susceptible to the disease. These are often ‘polyvalent’ vaccines, meaning they are directed against multiple strains of the virus, and are dispensed in large numbers in order to halt cross border transmission. They are special in regard to those countries, which are free from FMD but is always good to contain it with definite measures. Autonomous and combined organizations such as the WOAH will always ensure that emergency vaccines for FMD are stored to facilitate quick control of any FMD related exigency.

• Conventional Vaccines: Sanitary vaccines, on the other hand, are employed in normal immunization crusades in countries with the prevailing foot-and-mouth disease. These vaccines are routinely used in cattle to keep the immunity constant and to avoid incidence of the disease. Currently, traditional vaccines are primarily monovalent or bivalent, targeted at some of the most common strains in an area. It is for the prevaccination that these vaccines are deemed to play long-term control and eradication measures in the endemicy desert. These are commonly used in large quantities, and great efforts are made towards formulating better vaccines, longer lasting immunization and asking fewer doses.

BY APPLICATION

Based on application, the global market can be categorized into Cattle,Pig,Sheep and Goat

• CATTLE: FMD vaccines are vital for cattle because the former is sensitive to the virus and results in substantial losses in the abovementioned industry. FMD causes severe constrains in productivity among cattle especially the generation of low yields and shedding of weights in milk production and overweight cattle. The vaccines agent a way of eradicating epidemics thereby controlling spread of the virus within the herds in addition to minimizing mortality rates. FMD is common in many countries, so cattle are given regular booster shots in an attempt to prevent an outbreak of the disease.

• PIG: A vaccination is critical in pig farming, as the FMD virus infects almost all pigs in affected populations and has devastating effects. A pigs is an excellent host for the disease and after getting infected, it can transmit the virus through spread droplets and direct contact with the other pigs. It is also used to manage diseases’ incidences to reduce massive losses in the pork production.

• SHEEP: In sheep, FMD is caused by strains that may be different from those causing the disease in cattle and pigs; the disease has considerable economic effects even though it might be less severe in sheep than in other animals; the effects of FMD in mixed farming systems where sheep graze and share paddocks with other animals are especially devastating. It is well documented that vaccination of FMD in sheep is important in order to stop further circulation of the virus amongst animals including the vulnerable ones like cattle. Vaccination also affords sheep from productivity losses such as reduced wool/mineral yield and meat output that is very important for farmers.

• GOATS: Goats like sheep get affected by the FMD leading to mild to moderate signs but are good facilitators of the virus. In developing regions that own goats as their main source of milk, meat and fibers, FMD vaccination fosters food security together with minimizing the losses. Goat farmers cannot afford to wait for clinical signs before administering vaccines – this should be done through routine exercise in mixed-species farming system. Vaccinating goats can help prevent FMD from affecting agricultural business in rural areas or putting lives of larger susceptible livestock such as cattle or pigs in danger.

MARKET DYNAMICS

DRIVING FACTORS

"Rising Incidence of FMD to Boost the Market"

A factor in the Foot And Mouth Disease (FMD) Vaccines Market growth is the rising focus on rising Incidence of FMD. The rise of foot and mouth diseases in many parts of the world and especially in developing countries where live stok is key in food production to fuels the FMD vaccines market. Through reduced productivity, the disease has a huge cost implication in terms of yields in milk, meat and other products from livestock. Such escalation in disease outbreak frequency makes it mandatory to use vaccines in order not to affect the economy badly.

"Expansion of the Livestock Industry to Expand the Market:"

The growth of the livestock industry around the world particularly in emerging markets has also been a factor to the growth of FMD vaccines. The DRC of increasing populace, altering choice and congestion level, have equally enhanced the call for safeguarding livestock from FMD. Large agricultural producers are directing attention to enhance animal health, which will increase the demand for FMD vaccines even more.

RESTRAINING FACTOR

"High Cost of Vaccine Development and Distribution Of Foot and Mouth Disease (FMD) Vaccines to Potentially Impede Market Growth:"

The high cost of vaccine development and distribution serves as a significant restraining factor in the Foot And Mouth Disease (FMD) Vaccines Market. Developing vaccines for FMD involves extensive research, rigorous clinical trials, and adherence to stringent regulatory standards, all of which drive up production costs. Additionally, maintaining the cold chain during distribution to ensure vaccine efficacy adds further logistical and financial burdens, particularly in rural or resource-limited regions. These elevated costs can limit the ability of governments and organizations, especially in low-income countries, to implement widespread vaccination programs, thus restraining market growth.

OPPORTUNITY

"Technological Advancements in Vaccine Development To Create Opportunity for the Product in the Market:"

Biotechnology, new approaches to creating and producing effective vaccines, and the use of so-called synthetic vaccines also represent huge opportunities for development. New products that can provide a longer immunity or shots. Doctors could benefit from new methods that can last longer and be administered in fewer sessions. This is more so where accessing new vaccine doses on a regular basis may prove cumbersome due to large distances to travel. The disease is highly contagious, and companies willing to spend their money towards doing proper research, come up with better vaccines with easy ways of administering them stand to gain a competitive edge.

CHALLENGE

"Stringent Regulatory Requirements of Foot and Mouth Disease (FMD) Vaccines Could Be a Potential Challenge for Consumers:"

This is because the approval process of veterinary vaccines including FMD vaccines, is usually lengthy and cumbersome. Every country has its own regulatory rules and it can take much time and money to meet these criteria. This may slow the rate at which new vaccines are developed and launched into the market as well as increase operational costs for manufacturers especially for players in the small end of the value chain.

• • 

    Request a Free sampleto learn more about this report.

•  

FOOT AND MOUTH DISEASE (FMD) VACCINESMARKET REGIONAL INSIGHTS

NORTH AMERICA

(U.S. COMPULSORY) North America is the fastest-growing region in this market. Currently, the Foot And Mouth Disease (FMD) Vaccines Market in North America, especially in the United States is growing at a moderate rate the due to availability of several favorable regulatory policies in the region and disease free status which does not permit occurrence of large epidemic episodes. Nevertheless, great attention paid to potential outbreaks boosts the need for the vaccines, particularly in the areas where the livestock is present.

EUROPE

In Europe the market is more saturated, people get vaccinated annually for flu and citizens in some countries get vaccinated when there is an outbreak especially in some part of eastern Europe. The region also spends more in provision of preventive and control measures, animal health programs and in research on better vaccines.

ASIA 

FMD still poses a threat in Asia predominantly in countries such as India and China. As there is a high population of livestock and frequent occurrence of FMD, the consumption of FMD vaccines remains high and is increasing due to vaccination campaigns by most governments. This region poses the highest potential because it combines both preventive and control measures.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market Through Innovation and Market Expansion"

Key enterprise players are shaping the Foot And Mouth Disease (FMD) Vaccines Market place through strategic innovation and marketplace growth. The establishing of new subtypes of vaccines including inactivated and recombinant ones improves efficacy and reduces the number of adverse effects, which leads to the growing interest of livestock producers. Moreover, changes in delivery technology including needle-free administration and enhancement of adjuvants optimise immunogenicity and lessen stress inherent in vaccination in animals. This is due to increasing knowledge and sensitivity of the diseased’s effect on market and income among the governments and private counterparts leading to offering of vaccines and other research activities. Also, increase in trade and movement of livestock across borders, requires stronger measures in controlling the FMD and in turn drive the market for effectant vaccines.

LIST OF TOP FOOT AND MOUTH DISEASE (FMD) VACCINES COMPANIES

• Jinyu Group (China)
• Indian Immunologicals (India)
• Tecon Group(India)
• Biogenesis Bagó (Argentina)
• Boehringer Ingelheim (Germany)

KEY INDUSTRY DEVELOPMENT

June 2018: Authorities at Chandigarh Zoo is to vaccinate more than 100 animals for foot-and-mouth disease at the Mahendra Chaudhary Zoological Park, popularly known as Chhatbir Zoo, and will conduct vaccination of over 100 animals in the coming months

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The Foot and Mouth Disease (FMD) Vaccinesmarket is poised for a continued boom pushed by increasing health recognition, the growing popularity of plant-based diets, and innovation in product services. Despite challenges, which include confined uncooked fabric availability and better costs, the demand for gluten-unfastened and nutrient-dense alternatives supports marketplace expansion. Key industry players are advancing via technological upgrades and strategic marketplace growth, enhancing the supply and attraction of Foot and Mouth Disease (FMD) Vaccines flour. As customer choices shift towards healthier and numerous meal options, the Foot and Mouth Disease (FMD) Vaccinesmarket is expected to thrive, with persistent innovation and a broader reputation fueling its destiny prospects.